Literature DB >> 24584812

Photodynamic inactivation of staphylococci with 5-aminolaevulinic Acid or photofrin.

S Karrer1, R M Szeimies, S Ernst, C Abels, W Bäumler, M Landthaler.   

Abstract

Widespread use of antibiotics for bacterial infections is a reason for antibiotic resistance. Therefore, alternatives like photodynamic therapy (PDT) are studied for bacterial eradication.The viability of Staphylococcus (S.) aureus and S. epidermidis was studied following photosensitisation with different concentrations of 5-aminolevulinic acid (5-ALA) or Photofrin(®) and irradiation with a dye laser. After ALA without irradiation growth of S. epidermidis was reduced, surprisingly growth of S. aureus significantly increased. Using ALA and light a significant and concentration-dependent decrease of bacterial growth was measured in both strains. However, for S. epidermidis there was no difference between ALA with or without irradiation. Photofrin without light decreased bacterial growth significantly, indicating a high dark toxicity of the drug. Photofrin and light lead to a highly significant reduction of growth in both strains.While 5-ALA killed only up to 39% of Staphylococci, Photofrin was able to eradicate up to 93% of the bacteria. The poor response to 5-ALA may be due to an insufficient synthesis of photodynamically active porphyrins in Staphylococci. Although topical PDT could be useful for superinfected wounds or leg ulcers, the in-vitro bactericidal effect of 5-ALA PDT on staphylococci was not satisfactory.

Entities:  

Year:  1999        PMID: 24584812     DOI: 10.1007/s101030050021

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  1 in total

1.  Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives.

Authors:  Nicolas Fotinos; Maruska Convert; Jean-Claude Piffaretti; Robert Gurny; Norbert Lange
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.